BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 22534784)

  • 21. Genetic variants on 15q25.1, smoking, and lung cancer: an assessment of mediation and interaction.
    VanderWeele TJ; Asomaning K; Tchetgen Tchetgen EJ; Han Y; Spitz MR; Shete S; Wu X; Gaborieau V; Wang Y; McLaughlin J; Hung RJ; Brennan P; Amos CI; Christiani DC; Lin X
    Am J Epidemiol; 2012 May; 175(10):1013-20. PubMed ID: 22306564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beyond cigarettes per day. A genome-wide association study of the biomarker carbon monoxide.
    Bloom AJ; Hartz SM; Baker TB; Chen LS; Piper ME; Fox L; Martinez M; Hatsukami D; Johnson EO; Laurie CC; Saccone NL; Goate A; Bierut LJ
    Ann Am Thorac Soc; 2014 Sep; 11(7):1003-10. PubMed ID: 25072098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contribution of Variants in CHRNA5/A3/B4 Gene Cluster on Chromosome 15 to Tobacco Smoking: From Genetic Association to Mechanism.
    Wen L; Jiang K; Yuan W; Cui W; Li MD
    Mol Neurobiol; 2016 Jan; 53(1):472-484. PubMed ID: 25471942
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Strong association between two polymorphisms on 15q25.1 and lung cancer risk: a meta-analysis.
    Gu M; Dong X; Zhang X; Wang X; Qi Y; Yu J; Niu W
    PLoS One; 2012; 7(6):e37970. PubMed ID: 22701590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The relationship between CHRNA5/A3/B4 gene cluster polymorphisms and lung cancer risk: An updated meta-analysis and systematic review.
    Yi X; Li W; Wang Y; Chen X; Ye F; Sun G; Chen J
    Medicine (Baltimore); 2021 Feb; 100(6):e24355. PubMed ID: 33578531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Different effects of the three polymorphisms on 15q25.1 onlung cancer risk: Evidence from published literatures.
    Sun H; Pan Y; He B; Deng Q; Ying H; Chen J; Liu X; Wang S
    J Cancer Res Ther; 2016; 12(1):12-9. PubMed ID: 27072204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The 15q24/25 susceptibility variant for lung cancer and chronic obstructive pulmonary disease is associated with emphysema.
    Lambrechts D; Buysschaert I; Zanen P; Coolen J; Lays N; Cuppens H; Groen HJ; Dewever W; van Klaveren RJ; Verschakelen J; Wijmenga C; Postma DS; Decramer M; Janssens W
    Am J Respir Crit Care Med; 2010 Mar; 181(5):486-93. PubMed ID: 20007924
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of the nicotine metabolite ratio and CHRNA5/CHRNA3 polymorphisms with smoking rate among treatment-seeking smokers.
    Falcone M; Jepson C; Benowitz N; Bergen AW; Pinto A; Wileyto EP; Baldwin D; Tyndale RF; Lerman C; Ray R
    Nicotine Tob Res; 2011 Jun; 13(6):498-503. PubMed ID: 21385908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between CYP2A6 and CHRNA5-CHRNA3-CHRNB4 variation and smoking behaviors and lung cancer risk.
    Wassenaar CA; Dong Q; Wei Q; Amos CI; Spitz MR; Tyndale RF
    J Natl Cancer Inst; 2011 Sep; 103(17):1342-6. PubMed ID: 21747048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Novel Tobacco Use Phenotype Suggests the 15q25 and 19q13 Loci May be Differentially Associated With Cigarettes per Day and Tobacco-Related Problems.
    Richmond-Rakerd LS; Otto JM; Slutske WS; Ehlers CL; Wilhelmsen KC; Gizer IR
    Nicotine Tob Res; 2017 Apr; 19(4):426-434. PubMed ID: 27663783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chromosome 15q25 (CHRNA3-CHRNB4) Variation Indirectly Impacts Lung Cancer Risk in Chinese Males.
    Zhang Y; Jiang M; Li Q; Liang W; He Q; Chen W; He J
    PLoS One; 2016; 11(3):e0149946. PubMed ID: 26942719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The polymorphism of the CHRNA5 gene and the strength of nicotine addiction in lung cancer and COPD patients.
    Wojas-Krawczyk K; Krawczyk P; Biernacka B; Grzybek M; Kołodziej P; Kucharczyk T; Mlak R; Milanowski J
    Eur J Cancer Prev; 2012 Mar; 21(2):111-7. PubMed ID: 21955800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fine-mapping of the 5p15.33, 6p22.1-p21.31, and 15q25.1 regions identifies functional and histology-specific lung cancer susceptibility loci in African-Americans.
    Walsh KM; Gorlov IP; Hansen HM; Wu X; Spitz MR; Zhang H; Lu EY; Wenzlaff AS; Sison JD; Wei C; Lloyd SM; Chen W; Frazier ML; Seldin MF; Bierut LJ; Bracci PM; Wrensch MR; Schwartz AG; Wiencke JK; Amos CI
    Cancer Epidemiol Biomarkers Prev; 2013 Feb; 22(2):251-60. PubMed ID: 23221128
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nicotinic Receptor Alpha-5 Subunit Gene Polymorphism is Associated with Heavy Smoking Under a Range of Nicotine Dosing Conditions.
    Zuo Y; Rose JE; Davis JM; Behrens KA; Golaub AA; Chandra UU; Aarons EK; Morgan-Glover JD; Mukhin AG
    Nicotine Tob Res; 2024 Apr; ():. PubMed ID: 38654694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Susceptibility locus for lung cancer at 15q25.1 is not associated with risk of pancreatic cancer.
    Chen J; Wu X; Pande M; Amos CI; Killary AM; Sen S; Frazier ML
    Pancreas; 2011 Aug; 40(6):872-5. PubMed ID: 21697764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigating the possible causal association of smoking with depression and anxiety using Mendelian randomisation meta-analysis: the CARTA consortium.
    Taylor AE; Fluharty ME; Bjørngaard JH; Gabrielsen ME; Skorpen F; Marioni RE; Campbell A; Engmann J; Mirza SS; Loukola A; Laatikainen T; Partonen T; Kaakinen M; Ducci F; Cavadino A; Husemoen LLN; Ahluwalia TS; Jacobsen RK; Skaaby T; Ebstrup JF; Mortensen EL; Minica CC; Vink JM; Willemsen G; Marques-Vidal P; Dale CE; Amuzu A; Lennon LT; Lahti J; Palotie A; Räikkönen K; Wong A; Paternoster L; Wong AP; Horwood LJ; Murphy M; Johnstone EC; Kennedy MA; Pausova Z; Paus T; Ben-Shlomo Y; Nohr EA; Kuh D; Kivimaki M; Eriksson JG; Morris RW; Casas JP; Preisig M; Boomsma DI; Linneberg A; Power C; Hyppönen E; Veijola J; Jarvelin MR; Korhonen T; Tiemeier H; Kumari M; Porteous DJ; Hayward C; Romundstad PR; Smith GD; Munafò MR
    BMJ Open; 2014 Oct; 4(10):e006141. PubMed ID: 25293386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variant within the promoter region of the CHRNA3 gene associated with FTN dependence is not related to self-reported willingness to quit smoking.
    Marques-Vidal P; Kutalik Z; Paccaud F; Bergmann S; Waeber G; Vollenweider P; Cornuz J
    Nicotine Tob Res; 2011 Sep; 13(9):833-9. PubMed ID: 21511889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association study of nicotinic acetylcholine receptor genes identifies a novel lung cancer susceptibility locus near CHRNA1 in African-Americans.
    Walsh KM; Amos CI; Wenzlaff AS; Gorlov IP; Sison JD; Wu X; Spitz MR; Hansen HM; Lu EY; Wei C; Zhang H; Chen W; Lloyd SM; Frazier ML; Bracci PM; Seldin MF; Wrensch MR; Schwartz AG; Wiencke JK
    Oncotarget; 2012 Nov; 3(11):1428-38. PubMed ID: 23232035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CHRNA5 rs16969968 polymorphism is associated with lung cancer risk: A meta-analysis.
    Zhou W; Zhu W; Tong X; Ming S; Ding Y; Li Y; Li Y
    Clin Respir J; 2020 Jun; 14(6):505-513. PubMed ID: 32049419
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variants in the 15q25 gene cluster are associated with risk for schizophrenia and bipolar disorder.
    Jackson KJ; Fanous AH; Chen J; Kendler KS; Chen X
    Psychiatr Genet; 2013 Feb; 23(1):20-8. PubMed ID: 23196875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.